PALATINE, Ill., March 2, 2010 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (Nasdaq:ACUR) today reported a 2009 net loss of $15.8 million or $0.35 per share compared to net income of $14.5 million or $0.29 per diluted share for 2008. For the quarter ended December 31, 2009, we had a net loss of $4.1 million, or $0.09 per share compared to a net loss of $3.0 million, or $0.07 per share for the same quarter in 2008. As of March 1, 2010, we had cash and cash equivalents of approximately $28.4 million with no term indebtedness.
